Life Sciences BPO Market Projected to Grow at a CAGR of 21.5% between 2013 and 2019

Transparency Market Research

As the life sciences industry becomes increasingly competitive while being pressured by regulatory mandates, business process outsourcing (BPO) is being considered as an effective way to improve operational performance.

Source :

The market for life sciences BPO is comprised of two distinct entities offering their services to biotech and pharmaceutical companies—Contract Research Organizations and Contract Manufacturing Organizations.

But what are the factors that have given rise to a demand for life science BPO services? The pharma industry is constantly grappling with patent expirations, a pressure to develop low-cost drugs, and the growing uncertainty in economic conditions. Companies in this domain thus need to approach their core operations with singular focus. This is where life science BPO enterprises come into the picture with their support services. Pharma companies outsource various functions and non-core operations to third parties with a view to streamlining their value chain and cutting costs.

These partnerships are usually forged in the form of long-term contracts and partnerships with CMOs and CROs. Through these partnerships, pharma companies share costs right from drug discovery and development to licensing to approvals with the CMOs and/or CROs.

Pharma companies are also experiencing effective outcomes via life science BPOs; the latter leverage their experience, trained professionals, and latest technology to the advantage of the former.

Browse the full report PDF with TOC : Life Sciences BPO Market to be Worth USD 596 Billion by 2019

On the other hand, life-science BPOs too have been driven by the pressure to compete and achieve profitability. They try to accomplish this by introducing novel strategies to offer their clients a competitive advantage. According to a market research report published by U.S.-based market research firm Transparency Market Research, the global life sciences BPO market is projected to record a compounded annual growth rate (CAGR) of 21.5% between 2013 and 2019. Experts predict a healthy growth rate thanks to factors such as increased R&D investments by pharmaceutical companies, a spike in the demand for generic drugs, as well as a myriad of block buster drugs nearing the end of their patents. Other factors that have created a favorable environment for life science BPO include stringent regulatory mandates and government pressure to develop affordable drugs.

The Contract Manufacturing Organizations Market

According to the market research report published by Transparency Market Research, the CMO life science services outsourcing currently holds the largest share in the Life Sciences BPO market. The growth in healthcare costs has subsequently caused an increased generic drug demand, which has in turn led to a spike in the demand for the services of pharmaceutical outsourcing enterprises. Moreover, most CMOs have full-fledged R&D centers that employ novel technologies to give their clients an edge.

The market for active pharmaceutical ingredients (API) is the largest within the CMO segment. With mounting regulatory compliance and stringent approval parameters, the outsourcing of manufacturing activities to CMOs has received a boost.

At a time when manufacturers are striving to stay abreast of the latest regulatory mandates and industry breakthroughs, continually investing in facility upgrades might not be possible. This is another factor that can be attributed to the surge in demand for outsourcing partners as manufacturers do not possesses every required technology or expertise in-house. In such scenarios, outsourcing not only gives them access to the latest manufacturing technologies, but also proves to be a cost effective strategy.

The Contract Research Organizations (CRO) Market

Over the past decade, there has been considerable growth in the outsourcing services offered by CROs. Many pharmaceutical companies have been struggling to find a balance between mounting research costs and profitability. This has led many of these firms to turn towards CROs as a feasible option. The vendors operating in the market currently offer a combination of various services such as research, regulatory co-ordination services, data management, website management, medical writing, protocol development and others.

In 2012, the largest segment within this market was drug discovery. A report by Transparency Market Research however projects that between 2013 and 2019, the highest growth will be seen in the clinical data management BPO services at the rate of 17.3%.

Growth Projections

It is estimated that the Life Sciences BPO Market will be worth USD 596 billion worldwide by 2019, according to the Transparency Market Research report. And, while North America held the largest share in this market in 2012 with a worth of USD 28.4 billion, future growth is expected to be the highest in the Asia Pacific region with an approximate growth rate of 21.2% driven by various factors such as low cost of labor, availability of a talent pool, a large patient population, and comparatively favorable regulatory policies.



Organ Preservation Solutions Market Expected to Reach USD 0.20 Billion Globally in 2019


Organ Preservation Solutions Market (By Solutions – Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019


According to a new market report published by Transparency Market Research  Organ Preservation Solutions Market (By Solutions-Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013      2019,  in 2012, the global organ preservation solutions marketwas valued at USD 0.06 billion and is expected to grow at a CAGR of 16.5% during the forecast period 2013 to 2019 to reach a market value of USD 0.20 billion by 2019.

Browse Organ Preservation Solutions Market Report with Full TOC at

Organ preservation solutions help in preserving organs for long when they are not inside the living body,which makes them vulnerable to environment outside the human body.Organs that are removed from the human body are preserved using these solutions for various purposes such as organ transplant proceduresandresearch and development of drugs and biologics. The global market for organ preservation solutionshas been estimated togrowat the rate of 16.5% during the forecast period 2013 to 2019. This growth will be primarily driven by the increasing number of patients who are awaiting organ transplants, since these preservation solutions will enable survival of the organs outside the human body post donation by living or deceased donors. In addition, the rising incidences of organ failure in the patient population owing to changes in lifestyles such as smoking, alcohol and fast foodconsumption, along with rise in geriatric population, especially in developed nations such as U.S. and U.K., will also propel the growth of this market. Likewise, increase in per capita healthcare expenditure and theimprovingreimbursement scenarios for organ transplant procedures in various nations such as U.S., U.K. and India will also support the growth of this market.

Transparency Market Research

This report studiesthe market foreight major solutions for preserving organs, amongst which Viaspan and Custodiol together account for the majority share (over75%) of total market in terms of revenue. During the forecast period 2013 to 2019, the Custodiol market is expected to grow at the highest CAGR of 17.1%. This growth is attributed to its extensive utilization for preserving various organs such as kidney and liver, since it is capable of preserving multiple organs unlike other solutions including Perfadex and HBS solution.

Browse the full report PDF with TOC : Organ Preservation Solutions Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The different techniques utilized to preserve organs are static cold storage (SCS),hypothermic perfusion preservation (HPP) and others. HPP is a machine perfusion technique and maintains continuous supply of the solution needed by organs, unlike SCS that does not allow continuous contact of the organ with the solution.This property increases the survival duration of organs which will in turn augment its demand in the market. The HPP market is expected to grow at a CAGR of 19.2% during the forecast period 2013 to 2019.

The European region accounted for the largest share in terms of revenue of the total global organ preservation solutions market in 2012, and is expected to grow at the highest CAGR of 17.3% during the forecast period 2013 to 2019. This is due to the presence of a large number of organ donors in the region. For instance, in 2011 total number of deceased organ donors in the U.K. was around 1,056 according to the European Commission (EC). Also, the European region exhibited highest rate of aging of population which will also help propel the growth of this market.

The global organ preservation solutions market is ruled by players such as Teva Pharmaceutical Industries Ltd.,Bristol-Myers Squibb, Dr. Franz KöhlerChemie GmbH, XVIVO Perfusion AB andBioLife Solutions, Inc. These companies together accounted for around 90% of the total market revenue in 2012. Some other important players operating in the market include CryoLife, Inc., Lifeline Scientific, Claris Lifesciences Ltd., 21st Century Medicine and BioTime, Inc.

The global organ preservation solutions market has been segmented as below:

Organ Preservation Solutions Market, by Solution 
  • Viaspan
  • Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)
  • Renograf
  • Hypothermosol
  • Perfadex
  • Lifor
  • Human bioSystem (HBS) Solution
  • siRNA Transplant Solutions
  • Others
Organ Preservation Solutions Market, by Preservation Technique
  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others
Organ Preservation Solutions Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Related Report : 

Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

A rising tide of regulatory expectations, tougher inspection regime and instant need of patient reporting has provided the much needed impetus for the growth of the pharmacovigilance market. An upsurge in number of acute and chronic diseases has consequently led to a rise in number of drug consumption, which has also elicited a growth in the number of adverse drug events and drug toxicity cases. Moreover, several high-profile safety issues, regulatory warnings, large volume of events to be reviewed along with negative media coverage have compelled the pharmaceutical players to take support of various outsourcing services. There are two major outsourcing services opted by these pharmaceutical players i.e. traditional CROs and BPOs. These outsourcing services not only provide cost savings but also helps in bringing process efficiency. Pharmaceutical companies are now forming long term partnership with the CROs and BPOs to share the costs involved in PV process right from drug discovery to post marketing approvals. In addition, PV requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting.

The research report on pharmacovigilance provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of pharmacovigilance market on the bases of clinical trials phases i.e. Phase I to III and post marketing surveillance (PMS). We have also mapped the trend for preference of the pharmaceutical players for in-house and outsourcing in our chapter by type of service.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact us :

Sheela AK

90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Browse all Pharmaceutical Market Research Reports @